107 related articles for article (PubMed ID: 17300628)
1. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Mugittu K; Priotto G; Guthmann JP; Kiguli J; Adjuik M; Snounou G; Beck HP; Mshinda H; Olliaro PL; Taylor WR
Trop Med Int Health; 2007 Feb; 12(2):219-23. PubMed ID: 17300628
[TBL] [Abstract][Full Text] [Related]
2. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
Mugittu K; Adjuik M; Snounou G; Ntoumi F; Taylor W; Mshinda H; Olliaro P; Beck HP
Trop Med Int Health; 2006 Sep; 11(9):1350-9. PubMed ID: 16930256
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Cattamanchi A; Kyabayinze D; Hubbard A; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2003 Feb; 68(2):133-9. PubMed ID: 12641400
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
[TBL] [Abstract][Full Text] [Related]
5. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.
Happi CT; Gbotosho GO; Sowunmi A; Falade CO; Akinboye DO; Gerena L; Kyle DE; Milhous W; Wirth DF; Oduola AM
Am J Trop Med Hyg; 2004 Jan; 70(1):20-6. PubMed ID: 14971693
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Guthmann JP; Ampuero J; Fortes F; van Overmeir C; Gaboulaud V; Tobback S; Dunand J; Saraiva N; Gillet P; Franco J; Denoncin A; van Herp M; Balkan S; Dujardin JC; D'Alessandro U; Legros D
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):485-92. PubMed ID: 15876443
[TBL] [Abstract][Full Text] [Related]
11. Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Aubouy A; Fievet N; Bertin G; Sagbo JC; Kossou H; Kinde-Gazard D; Kiniffo R; Massougbodji A; Deloron P
Trop Med Int Health; 2007 Jul; 12(7):886-94. PubMed ID: 17596256
[TBL] [Abstract][Full Text] [Related]
12. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
Martensson A; Ngasala B; Ursing J; Isabel Veiga M; Wiklund L; Membi C; Montgomery SM; Premji Z; Farnert A; Bjorkman A
J Infect Dis; 2007 Feb; 195(4):597-601. PubMed ID: 17230421
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
van den Broek IV; Maung UA; Peters A; Liem L; Kamal M; Rahman M; Rahman MR; Bangali AM; Das S; Barends M; Faiz AM
Trans R Soc Trop Med Hyg; 2005 Oct; 99(10):727-35. PubMed ID: 16095643
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy.
Slater M; Kiggundu M; Dokomajilar C; Kamya MR; Bakyaita N; Talisuna A; Rosenthal PJ; Dorsey G
Am J Trop Med Hyg; 2005 Aug; 73(2):256-62. PubMed ID: 16103584
[TBL] [Abstract][Full Text] [Related]
15. Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
Myrick A; Leemann E; Dokomajilar C; Hopkins H; Dorsey G; Kamya MR; Rosenthal PJ
Am J Trop Med Hyg; 2006 May; 74(5):758-61. PubMed ID: 16687676
[TBL] [Abstract][Full Text] [Related]
16. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
Djimdé AA; Fofana B; Sagara I; Sidibe B; Toure S; Dembele D; Dama S; Ouologuem D; Dicko A; Doumbo OK
Am J Trop Med Hyg; 2008 Mar; 78(3):455-61. PubMed ID: 18337343
[TBL] [Abstract][Full Text] [Related]
18. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
Burns M; Baker J; Auliff AM; Gatton ML; Edstein MD; Cheng Q
Am J Trop Med Hyg; 2006 Mar; 74(3):361-6. PubMed ID: 16525092
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
Cairo J; Durand S; Marquiño W; Cabezas C; Lachira A; Quintana F; Vegas W; Ruebush TK; Utz G; Bacon DJ
Am J Trop Med Hyg; 2008 Jul; 79(1):42-4. PubMed ID: 18606762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
